Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 10:31 AM ET

Date/Time Source News Release
04/25/2025 04:30 PM EDT GlobeNewswire Rezolute, Inc. Announces Closing of Underwritten Offering
04/23/2025 08:05 AM EDT GlobeNewswire Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
04/23/2025 08:00 AM EDT GlobeNewswire Rezolute Announces Positive Recommendation After Independent Interim Analysis of Phase 3 sunRIZE Study of Ersodetug in Congenital Hyperinsulinism ("HI")
03/26/2025 07:30 AM EDT GlobeNewswire Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors
02/12/2025 04:05 PM EST GlobeNewswire Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
02/04/2025 08:00 AM EST GlobeNewswire Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
01/31/2025 08:00 AM EST GlobeNewswire Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference
01/07/2025 08:00 AM EST GlobeNewswire Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
12/05/2024 08:00 AM EST GlobeNewswire Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
12/03/2024 08:00 AM EST GlobeNewswire FDA Grants Orphan Drug Designation to Rezolute's Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Page

Additional News

As of April 30, 2025 • 10:31 AM ET

Date/Time Source News Release
04/23/2025 01:30 PM EDT PRISM News PRISM Mid-Day Movers: Board Shakeups and Biotech Financings Drive Investor Focus
04/23/2025 01:05 PM EDT AllPennyStocks.com Biotech Stock Surges After Encouraging Data Monitoring Committee Recommendation
04/23/2025 09:59 AM EDT SeekingAlpha Rezolute gets positive recommendation from IDMC to continue Ersodetug study
04/23/2025 09:20 AM EDT SeekingAlpha Rezolute stock rises after pricing $90M securities offering
04/21/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Contract Breaches and Patent Allowances Spell Different Fates For AI and Weight Loss Indices
04/21/2025 10:43 AM EDT KlickAnalytics SPSB, VCSH, VGSH, SCHO, RZLT showing five-day upward surge
04/11/2025 12:00 PM EDT Zacks Rezolute (RZLT) Upgraded to Buy: What Does It Mean for the Stock?
03/12/2025 09:55 AM EDT Zacks Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing
02/18/2025 01:30 AM EST SeekingAlpha Rezolute: Late-Stage Study Targeting Hyperinsulinism
02/12/2025 05:41 PM EST SeekingAlpha Rezolute GAAP EPS of -$0.22 beats by $0.03
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.